At RayzeBio, we get it done. Every patient deserves access to the best possible treatment, and we’re committed to making a difference in the lives of people with cancer. Radiopharmaceutical therapy is positioned to revolutionize the treatment of cancer – RayzeBio, a Bristol Myers Squibb Company – is committed to advancing radiopharmaceutical therapies through the clinic and to more patients to change lives.
| Website | http://www.rayzebio.com |
| Revenue | $1.2 billion |
| Employees | 285 (227 on RocketReach) |
| Founded | 2020 |
| Phone | +1 858-257-3421 |
| Technologies |
JavaScript
,
HTML
,
PHP
+14 more
(view full list)
|
| Industry | Biotechnology Research, Drug Discovery, Biotechnology |
| Keywords | Therapeutic Radiopharmaceuticals, Breakthrough Therapies, Radioactive Pharmaceuticals, Innovative Therapies, Oncology Therapeutics, Targeted Therapy, Nuclear Medicine, Precision Medicine, Cancer Treatment, Molecular Imaging, Advanced Therapies, Biotechnology, Pharmaceutical Development, Pharmaceutical Research, Pharmaceutical Manufacturing, Drug Development, Clinical Trials |
| Competitors | Bayer, Novartis, Pfizer, Bristol Myers Squibb, Amgen, GSK, AstraZeneca, Regeneron, Lilly India, Sanofi +38 more (view full list) |
Looking for a particular RayzeBio employee's phone or email?
The RayzeBio annual revenue was $1.2 billion in 2026.
Abhijit Bhat is the SVP, Head of Discovery of RayzeBio.
227 people are employed at RayzeBio.
RayzeBio is based in San Diego, California.